Acetylation, Slow

Table of contents:

Description
Related genes
Clinical Features
Incidence and onset information
Alternative Names
Researches and researchers
Gene Panels
Sources and references

Genes related to Acetylation, Slow

NAT2

View recommended genes panels

Clinical Features

Phenotypes and symptoms related to Acetylation, Slow

Neoplasm
Peripheral neuropathy
Abnormality of metabolism/homeostasis
Systemic lupus erythematosus
Bladder neoplasm

Incidence and onset information

— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)
— No data available about the known clinical features onset.

Alternative names

Acetylation, Slow Is also known as inh inactivation, slow, isoniazid inactivation, slow, slow acetylator phenotype.

Researches and researchers

Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.

Acetylation, Slow Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Pharmacogenetics (NAT2 polymorphisms). By CGC Genetics (Portugal). NAT2 Specificity 100 % Genes 100 %
Slow Acetylation, Drug-Induced Hepatotoxicity, and Other Adverse Drug Reactions via NAT2 Gene Sequencing with CNV Detection. By PreventionGenetics PreventionGenetics (United States). NAT2 Specificity 100 % Genes 100 %
Pharmacogenetic panel. By bio.logis Center for Human Genetics Diagnosticum (Germany). SLC19A1, SLCO1B1, SOD2, TPMT, UGT1A1, CCR5, VKORC1, ADH1B, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, ADRB3, DPYD, ABCB1, G6PD, MTHFR, NAT2 , (...) View the complete list with 2 more genes Panel complete gene list SLC19A1, SLCO1B1, SOD2, TPMT, UGT1A1, CCR5, VKORC1, ADH1B, CYP2B6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, CYP3A5, ADRB3, DPYD, ABCB1, G6PD, MTHFR, NAT2, OPRM1, BCHE Specificity 5 % Genes 100 %
NAT2. By MVZ Dortmund Dr. Eberhard & Partner (Germany). NAT2 Specificity 100 % Genes 100 %
*NAT2 (N-Acetylransferase): 5A, 6A, and 7A alleles screening.** By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases (Spain). NAT2 Specificity 100 % Genes 100 %
NAT2. By Fulgent Genetics Fulgent Genetics (United States). NAT2 Specificity 100 % Genes 100 %
NAT2. By Genelex (United States). NAT2 Specificity 100 % Genes 100 %
Slow acetylator due to N-acetyltransferase enzyme variant. By Labor Dr. Wisplinghoff (Germany). NAT2 Specificity 100 % Genes 100 %

You can get up to 1 more panels with our dedicated tool

Learn more

Sources and references

You can check the following sources for additional information.

OMIM Rare Disease Symptoms Checker

If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like UV-SENSITIVE SYNDROME 2; UVSS2 MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD HYPOMAGNESEMIA 5, RENAL, WITH OCULAR INVOLVEMENT; HOMG5 AMYOTROPHY, HEREDITARY NEURALGIC; HNA ABDOMINAL OBESITY-METABOLIC SYNDROME 1; AOMS1 OHDO SYNDROME, SBBYS VARIANT; SBBYSS CHROMOSOME 3q13.31 DELETION SYNDROME